Uk New Zealand Mutual Recognition Agreement

However, European Commission trade negotiators recently rejected mutual recognition of the compliance assessment by UK testing laboratories. The INTER agreement covers the following areas, where association agreements are trade agreements, which facilitate market access and promote greater international harmonisation of compliance standards while protecting consumer safety. The EU has mutual recognition agreements with several third countries. These agreements generally provide that a party accepts compliance assessment results (for example. B tests or certifications) issued by caBs designated by the other party to demonstrate compliance with the requirements of the first part. In other words, they allow the other party`s CABs to test products against the rules of the first part. As a general rule, they do not provide for mutual acceptance of standards and rules or the equivalence of those standards or rules. As a general rule, agreements also set the conditions for caB designation and recognition of compliance assessment. This facilitates trade by allowing exporters to obtain certificates required by the country of import in their home country.

The Johnson government has moved away from these approaches. In its proposal for a comprehensive free trade agreement with the EU, the UK proposes an agreement on mutual recognition of compliance assessment that is “consistent” with the provisions of the EU agreement with Canada. A separate agreement on the certification of marine equipment is also proposed as part of the agreement between the EU and the United States. This agreement will enter into force on 1 January 2021 when the EU-New Zealand agreement will no longer apply to the United Kingdom. Read the full evaluation of mutual recognition agreements and agreements for compliance assessment. [PDF, 346 KB] The treaty provides for mutual recognition of the UK-New Zealand compliance assessment. It is essential that “traditional” MRA does not require states to harmonize the rules (i.e. establishing technical standards and common rules) and do not require parties to one MRA to recognize each other`s requirements as equivalent – MRA is limited to the recognition of the partner`s CAB`s responsibility for assessing compliance. The transition period for human-use medicines under the agreement ended on 11 July 2019: the European Union (EU) has signed mutual recognition agreements with third-country authorities. These agreements contain a sectoral annex on mutual recognition of good manufacturing practice inspections (GMPs) and certification of batches of medicines for human and veterinary use. During a transitional period, the authorities assess each other`s pharmaceutical legislation, guidelines and regulatory systems under the agreement. The EU internal market is the most comprehensive version of mutual recognition between trading partners.

According to the Dijon Cassis principle, a product that can be legally sold in one Member State can be legally sold in any other Member State, even if the rules are not harmonised. Although there has been little progress in accession negotiations, Turkey has gradually expanded its legislation on EU legislation to remove technical barriers. The results of THE CAB tests notified by Turkey are mutually recognised in the EU (and vice versa).